Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E in Aging Persons With Down Syndrome
NCT00056329Phase 3Unknown
- Sponsor
- New York State Institute for Basic Research in Developmental Disabilities
- Start
- Apr 2002
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Vitamin E with Placebo (2 arms). Primary endpoint: Brief Praxis Test at 36 months. Status: unknown.
02
Drugs
vitamin e
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00056329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056329.